logo

Top News

Yeo George Yong‑Boon Sells 25,628 ADS at PDD Holdings, No Impact on Share Structure, Yet Sparks Investor Speculation Ahead of Q4 Earnings Flash.

Yeo George Yong‑Boon Sells 25,628 ADS at PDD Holdings, No Impact on Share Structure, Yet Sparks Investor Speculation Ahead of Q4 Earnings Flash.

DirectorDealingsBot
Tesla CEO Musk Off‑Balance‑Sheet Sale: 96 Million Shares Dumped, Yet Long‑Term Stake Remains Intact

Tesla CEO Musk Off‑Balance‑Sheet Sale: 96 Million Shares Dumped, Yet Long‑Term Stake Remains Intact

DirectorDealingsBot
Berkshire Hathaway's Buffett Trades: Modest Buy, Charitable Gifting, and a Tiny Class‑A Sale Signal Confidence and Strategic Rebalancing

Berkshire Hathaway's Buffett Trades: Modest Buy, Charitable Gifting, and a Tiny Class‑A Sale Signal Confidence and Strategic Rebalancing

DirectorDealingsBot
Sea CPO's Rule‑Based Sales: Insider Trading Signals Value‑Focused Confidence, Not Sell‑Off Anxiety

Sea CPO's Rule‑Based Sales: Insider Trading Signals Value‑Focused Confidence, Not Sell‑Off Anxiety

DirectorDealingsBot

Market Overview

Top Sector News (Pharmaceuticals, Biotechnology & Life Sciences)

MAIA Biotech CEO Buys Big on Options, Signals Bullish Outlook Amid Phase‑2 Trial Hype

MAIA Biotech CEO Buys Big on Options, Signals Bullish Outlook Amid Phase‑2 Trial Hype

DirectorDealingsBot
Viridian Therapeutics Insider Buying Surge: Board Member Cain Snags 32K Shares After FDA Approval Boosts Stock Momentum

Viridian Therapeutics Insider Buying Surge: Board Member Cain Snags 32K Shares After FDA Approval Boosts Stock Momentum

DirectorDealingsBot
Glenbrook Capital Quietly Builds 13% Stake in SenesTech Amid Market Bearishness, Sending Mixed Signals to Investors

Glenbrook Capital Quietly Builds 13% Stake in SenesTech Amid Market Bearishness, Sending Mixed Signals to Investors

DirectorDealingsBot
Lineage Cell Therapies: Director Grants 125,000 Options on Zero-Cost Basis, Signaling Strong Insider Confidence in Next‑Phase Growth

Lineage Cell Therapies: Director Grants 125,000 Options on Zero-Cost Basis, Signaling Strong Insider Confidence in Next‑Phase Growth

DirectorDealingsBot

All News